The implementation of buprenorphine/naloxone in college health practice.
Opiate abuse and dependence have become important concerns for college healthcare providers. The passage of the Drug Addiction Treatment Act of 2000 and the approval of the combination buprenorphine/naloxone for office-based treatment of opiate dependence have increased the options available for college students and their healthcare providers. The authors review the pharmacology of buprenorphine/naloxone and discuss how it can be implemented in college health practice. They also present a case report.
DeMaria
Peter A
PA
Tuttleman Counseling Services, Temple University, 1810 Liacouris Walk, Philadelphia, PA 19122, USA. pdemaria@temple.edu
Patkar
Ashwin A
AA
D000328:Adult; D002047:Buprenorphine / Q000494:pharmacology* / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination; D004338:Drug Combinations; D006801:Humans; D008297:Male; D009270:Naloxone / Q000494:pharmacology* / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D013333:Student Health Services / Q000458:organization & administration*
D000069479:Buprenorphine, Naloxone Drug Combination; D004338:Drug Combinations; D009270:Naloxone; D002047:Buprenorphine